Home  >> Transactions>> AHN biotechnologie has been sold to Capp

AHN biotechnologie has been sold to Capp

Harvard Bioscience, Inc. (Nasdaq: HBIO) has sold its subsidiary, AHN Biotechnologie GmbH, to Capp ApS. Based in Nordhausen, Germany, AHN Biotechnologie specializes in the development, manufacturing and distribution of liquid handling products for the use in laboratories worldwide.

Others

Entegris Has Acquired Flex Concepts, Inc.      Learn More >>
Hänsel Group has sold a majority stake to Possehl      Learn More >>
Entegris has acquired SAES Pure Gas Business from SAES Group      Learn More >>
Ldetek has been sold to Battery Ventures’ Process Sensing Technologies Group      Learn More >>
Axel Johnson International acquires MAK Aandrijvingen      Learn More >>
SPX has acquired CUES, Inc.      Learn More >>
Dickson Data has been sold to May River Capital      Learn More >>
SPX has acquired Schonstedt Instrument Company      Learn More >>
Quantachrome Instruments has been sold to Anton Paar      Learn More >>
PIP Global has partnered with Audax Private Equity      Learn More >>
Harvard Bioscience has acquired Data Sciences International      Learn More >>
Horizon Technology has been sold to Biotage      Learn More >>